Filter the latest scan's published facts — sector, size, yield, valuation — or rank them with a preset: cheapest, fastest growing, most profitable. Every view shows what is in the filings and prices; none ranks opportunity. The model behind the statuses showed no predictive power, and nothing here is a recommendation.
Scan of 2026-08-31 · 2,409 names scored · prices as of that date
Highest trailing profitability and earnings quality versus sector peers, latest scan: sector percentiles on gross profitability, margins, cash conversion, returns on capital and the Piotroski F-score, averaged. A fact about the trailing record, not a claim that profitability persists or pays.
Tested the unforgiving way: a composite ranking built from these same point-in-time filings (2017-01-31 to 2026-05-29) showed no measurable predictive power (mean IC 0.0168, t = 1.21), and its top quintile did not beat holding everything even before costs. Ranks like these describe today's record; they do not predict tomorrow's return.
180 names — page 3 of 4 · sector: Healthcare · Export CSV
| # | Ticker | Company | Sector | Quality composite | ROIC (approx.) | Operating margin | Net margin | Piotroski F-score | Own 5y |
|---|---|---|---|---|---|---|---|---|---|
| 101 | SGRY | Surgery Partners, Inc. Common Stock | Healthcare | 46.9 | 20.6% |
Never the absolute multiple alone. A P/E of 9 is a fact; whether it is low depends on what you hold it against.
The five-year window is the empirically privileged one. Cheap against its sector and cheap against its own history are different claims, and a stock can be one without being the other — which is the whole reason both columns are shown rather than blended into a single score.
| -2.3% |
| 5 / 9 |
| — |
| 102 | FEIM | Frequency Electronics, Inc. | Healthcare | 46.8 | 11.0% | 9.8% | 10.6% | 4 / 9 | — |
| 103 | TXG | 10x Genomics, Inc. Class A Common Stock | Healthcare | 46.1 | -3.8% | -6.1% | -3.5% | 6 / 9 | — |
| 104 | ITGR | Integer Holdings Corporation | Healthcare | 45.5 | 6.2% | 11.0% | 7.6% | 7 / 9 | — |
| 105 | WRBY | Warby Parker Inc. | Healthcare | 44.9 | -4.5% | -0.7% | 0.2% | 6 / 9 | — |
| 106 | TRNS | Transcat Inc | Healthcare | 44.0 | 2.3%FY | 4.0%FY | 1.6%FY | 4 / 9FY | — |
| 107 | RDNT | RadNet, Inc. Common Stock | Healthcare | 43.7 | 2.8% | 2.9% | -0.7% | 5 / 9 | — |
| 108 | CDNA | CareDx, Inc. | Healthcare | 43.1 | -5.4% | -3.9% | -2.0% | 6 / 9 | — |
| 109 | ICUI | ICU Medical Inc | Healthcare | 43.0 | 1.3% | 2.0% | 2.1% | 6 / 9 | — |
| 110 | IRTC | iRhythm Holdings, Inc. Common Stock | Healthcare | 42.5 | — | -5.2% | -3.5% | 7 / 9 | — |
| 111 | WAT | Waters Corp | Healthcare | 41.6 | 2.6% | 16.0% | 11.9% | 5 / 9 | — |
| 112 | HIMS | Hims & Hers Health, Inc. | Healthcare | 41.4 | -10.8% | -1.3% | -0.6% | 3 / 9 | — |
| 113 | OMDA | Omada Health, Inc. Common Stock | Healthcare | 40.7 | -29.5% | -2.9% | -2.2% | — | — |
| 114 | SMTI | Sanara MedTech Inc. Common Stock | Healthcare | 38.9 | 17.9% | 8.5% | -31.2% | 5 / 9 | — |
| 115 | SIBN | SI-BONE, Inc. Common Stock | Healthcare | 38.7 | -8.7% | -9.7% | -8.1% | 7 / 9 | — |
| 116 | COHR | Coherent Corp. | Healthcare | 38.4 | — | — | 7.1% | 7 / 9 | — |
| 117 | SRTA | Strata Critical Medical, Inc. Class A Common Stock | Healthcare | 38.0 | -8.7% | -8.6% | 20.6% | 3 / 9 | — |
| 118 | KODK | EASTMAN KODAK COMPANY | Healthcare | 37.8 | 2.1% | 1.1% | -12.6% | 6 / 9 | — |
| 119 | INNV | InnovAge Holding Corp. Common Stock | Healthcare | 35.9 | -4.0% | -1.0% | -1.2% | 6 / 9 | — |
| 120 | PRPO | Precipio, Inc. Common Stock | Healthcare | 35.7 | -12.1% | -6.7% | -3.5% | 5 / 9 | — |
| 121 | ANIK | Anika Therapeutics Inc | Healthcare | 35.6 | -10.4% | -10.5% | -9.5% | 7 / 9 | — |
| 122 | AXGN | Axogen, Inc. Common Stock | Healthcare | 35.1 | -4.4% | -3.8% | -13.2% | 5 / 9 | — |
| 123 | OFIX | Orthofix Medical Inc. Common Stock (DE) | Healthcare | 35.1 | -6.9% | -5.7% | -7.3% | 5 / 9 | — |
| 124 | BLFS | BioLife Solutions Inc. | Healthcare | 33.7 | -3.6% | -15.8% | -2.9% | 6 / 9 | — |
| 125 | BRKR | Bruker Corporation | Healthcare | 33.7 | 0.6% | 1.3% | -0.3% | 4 / 9 | — |
| 126 | TNDM | Tandem Diabetes Care, Inc. | Healthcare | 33.5 | — | -8.2% | -9.2% | 6 / 9 | — |
| 127 | TDOC | Teladoc Health, Inc. | Healthcare | 32.8 | -27.5% | -8.1% | -6.8% | 6 / 9 | — |
| 128 | CSTL | Castle Biosciences, Inc. Common Stock | Healthcare | 32.7 | -6.5% | -9.8% | -3.8% | 3 / 9 | — |
| 129 | STAA | Staar Surgical Co | Healthcare | 32.4 | -9.4% | -9.1% | -7.2% | 5 / 9 | — |
| 130 | ANGO | AngioDynamics, Inc. | Healthcare | 32.4 | -20.7% | -11.3% | -10.0% | 6 / 9 | — |
| 131 | INTT | inTEST Corporation | Healthcare | 32.1 | 0.1% | 0.1% | 0.5% | 4 / 9 | — |
| 132 | BLCO | Bausch + Lomb Corporation | Healthcare | 32.0 | 1.6% | 4.4% | -4.2% | 4 / 9 | — |
| 133 | COHU | Cohu Inc | Healthcare | 30.1 | -7.6% | -11.1% | -11.5% | 5 / 9 | — |
| 134 | AVTR | Avantor, Inc. | Healthcare | 30.0 | -2.5% | -4.5% | -8.4% | 5 / 9 | — |
| 135 | AHCO | AdaptHealth Corp. Common Stock | Healthcare | 29.3 | 1.7% | 2.2% | -2.4% | 3 / 9 | — |
| 136 | INGN | Inogen Inc | Healthcare | 28.6 | -28.1% | -10.7% | -8.3% | 4 / 9 | — |
| 137 | BAX | Baxter International Inc. | Healthcare | 27.9 | -5.9% | -2.7% | -9.7% | 5 / 9 | — |
| 138 | KIDS | OrthoPediatrics Corp. Common Stock | Healthcare | 27.7 | -8.9% | -15.0% | -16.3% | 5 / 9 | — |
| 139 | WGS | GeneDx Holdings Corp. Class A Common Stock | Healthcare | 25.6 | -20.3% | -14.9% | -17.6% | 4 / 9 | — |
| 140 | ESTA | Establishment Labs Holdings Inc. | Healthcare | 24.9 | -11.6% | -12.4% | -19.1% | 5 / 9 | — |
| 141 | XRAY | DENTSPLY SIRONA Inc. | Healthcare | 24.1 | -13.1% | -14.1% | -17.1% | 4 / 9 | — |
| 142 | NPCE | Neuropace, Inc. Common Stock | Healthcare | 23.8 | -22.6% | -16.8% | -21.7% | 4 / 9 | — |
| 143 | NTRA | Natera, Inc. Common Stock | Healthcare | 23.6 | -13.8% | -13.0% | -9.0% | 4 / 9 | — |
| 144 | NVCR | NovoCure Limited Ordinary Shares | Healthcare | 22.3 | -59.6% | -27.2% | -25.7% | 4 / 9 | — |
| 145 | RAL | Ralliant Corporation | Healthcare | 22.2 | -38.4% | -56.0% | -58.6% | — | — |
| 146 | FTRE | Fortrea Holdings Inc. Common Stock | Healthcare | 21.6 | -19.6% | -13.1% | -16.5% | 5 / 9 | — |
| 147 | IART | Integra LifeSciences Holdings | Healthcare | 21.4 | -45.7% | -28.4% | -30.1% | 6 / 9 | — |
| 148 | SGHT | Sight Sciences, Inc. Common Stock | Healthcare | 20.7 | — | -44.8% | -46.8% | 4 / 9 | — |
| 149 | OPTX | Syntec Optics Holdings, Inc. Class A Common Stock | Healthcare | 20.5 | -12.5% | -6.6% | -11.0% | 3 / 9 | — |
| 150 | TFX | Teleflex Incorporated | Healthcare | 20.5 | 0.9% | 3.0% | -47.4% | 2 / 9 | — |
"Quality composite" is a 0–100 position among valid sector peers — the mean of the component metrics' sector percentiles. "—" means the scan published no figure, deliberately. "n/a — masked" means the metric is misleading in that name's sector (a REIT's GAAP P/E, a bank's FCF yield) — hover for the reason, which comes from the same sector-validity rules the composite itself respects. An FY tag marks a trailing-year figure built from an annual filing; hover for what that means.
